X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Clinical Lymphoma Myeloma & Leukemia

期刊標題檢索 最新評論: 沒有評論


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Clinical Lymphoma Myeloma & Leukemia]您好,您是該頁面的第 20262 位訪客。

期刊簡介
期刊名稱Clinical Lymphoma Myeloma & Leukemia Clinical Lymphoma Myeloma & Leukemia
LetPub Score
5.1
50 ratings
Rate

Reputation
6.3

Influence
3.6

Speed
7.0

期刊簡稱CL LYMPH MYELOM LEUK
ISSN2152-2650
E-ISSN2152-2669
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
2.700.5480.616
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q382 / 137
Category: Medicine
Subcategory: Oncology
Q3254 / 404
Category: Medicine
Subcategory: Cancer Research
Q4176 / 230

自引率 (2023-2024)3.70%自引率趨勢
掲載範囲
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
官方網站http://www.journals.elsevier.com/clinical-lymphoma-myeloma-and-leukemia
在線稿件提交http://ees.elsevier.com/clml/
開放訪問No
出版商Cancer Media Group
主題領域ONCOLOGY
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年2010
每年文章數134每年文章數趨勢
黃金OA百分比19.43%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ235/97
ONCOLOGYSCIEQ3163/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2152-2650%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【Clinical Lymphoma Myeloma & Leukemia】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    HemaSphereH-index: 0

    CiteScore: 6.10
    Journal of the National Cancer CenterH-index: 0

    CiteScore: 14.20
    Blood AdvancesH-index: 0

    CiteScore: 12.70
    Transplantation and Cellular TherapyH-index: 0

    CiteScore: 7.00
    Research and Practice in Thrombosis and HaemostasisH-index: 0

    CiteScore: 5.60
    Hematology-American Society of Hematology Education ProgramH-index: 83

    CiteScore: 4.70
    Current Hematologic Malignancy ReportsH-index: 28

    CiteScore: 6.00
    Thrombosis JournalH-index: 0

    CiteScore: 3.80
    Mediterranean Journal of Hematology and Infectious DiseasesH-index: 23

    CiteScore: 4.20
    Blood ScienceH-index: 0

    CiteScore: 1.70
    學科內最受檢索的期刊 頁面查看次數
    Blood Advances21813
    Thrombosis Journal12189
    Current Hematologic Malignancy Reports10497
    Indian Journal of Hematology and Blood Transfusion9454
    Hematology-American Society of Hematology Education Program8249
    Mediterranean Journal of Hematology and Infectious Diseases8204
    Blood Science4850
    Research and Practice in Thrombosis and Haemostasis4638
    Transplantation and Cellular Therapy4537
    HemaSphere4175
  •  

    Clinical Lymphoma Myeloma & Leukemia Clinical Lymphoma Myeloma & Leukemia
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    下一頁    末頁  (0/0)
  [Clinical Lymphoma Myeloma & Leukemia] 的評論撰寫評論
暫無評論。
首頁    上一頁    下一頁    末頁  (0/0)

開始撰寫 [Clinical Lymphoma Myeloma & Leukemia] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*